GCG and cardiovascular disorder: When it comes to the effect of GLP-1 analogues the reduction in postprandial glucose response, and insulinemia may actually contribute to weight loss, but also be the key drivers to the anti-diabetic effect and reduction in cardiovascular disease risks.